The Melanoma Antigen Gene (MAGE) family encompasses a group of proteins with a notable expression pattern primarily restricted to testicular germ cells under healthy conditions but aberrantly expressed in various types of cancer cells. The expression of MAGE proteins in tumors is of significant interest to the scientific community due to their role in cancer cell biology. While the physiological function of these proteins in normal cells remains incompletely understood, MAGE genes are known to be involved in regulating various cellular processes, including gene transcription, cell cycle progression, and apoptosis. The expression of MAGE proteins in cancer cells, as opposed to their restricted expression in normal tissues, provides a unique window into the complex regulatory mechanisms that govern cellular growth and differentiation.
A variety of chemical compounds have been identified that can potentially induce the expression of MAGE proteins. These compounds typically exert their effects through the modification of epigenetic marks or by influencing the cellular stress responses that can lead to changes in gene expression. Compounds such as 5-Azacytidine and Decitabine can induce hypomethylation of DNA at the promoter regions of silenced genes, including MAGE, thereby facilitating their transcription. Histone deacetylase inhibitors, like Trichostatin A, Vorinostat, and Sodium Butyrate, have been shown to increase the acetylation levels of histones, promoting a more relaxed and transcriptionally active chromatin structure around the MAGE gene loci. Additionally, chemicals that cause DNA damage, such as Temozolomide and Doxorubicin, can trigger cellular stress responses that may result in the elevated expression of MAGE proteins. Furthermore, compounds like Retinoic Acid can induce gene expression by activating nuclear receptors that bind to DNA response elements within the regulatory regions of target genes, including those of the MAGE family. The intricate interplay between these chemical compounds and cellular gene expression machinery elucidates the complexity of cellular regulation and highlights the precise control mechanisms cells have evolved to manage the expression of genes such as MAGE.
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methylation, 5-Azacytidine could reactivate epigenetically silenced promoters of the MAGE gene family, leading to their increased expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may specifically upregulate MAGE genes by preventing the deacetylation of histones, thus maintaining an open chromatin state conducive to transcription initiation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
The histone deacetylase inhibitory action of Sodium Butyrate might directly lead to hyperacetylation of histones associated with MAGE gene promoters, resulting in their enhanced transcription. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
Valproic Acid could stimulate the expression of MAGE proteins by creating an accessible chromatin environment through its HDAC inhibitory effect, thereby promoting gene activation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
5-Aza-2′-Deoxycytidine (Decitabine) may specifically target DNA methylation marks within the MAGE gene loci, leading to their demethylation and subsequent transcriptional upregulation. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
Suberoylanilide Hydroxamic Acid (Vorinostat) may facilitate the transcriptional commencement of MAGE genes by ensuring that histones remain acetylated, keeping the relevant DNA regions transcriptionally active. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
Disulfiram could potentially elevate MAGE gene expression by altering the ubiquitin-proteasome pathway, resulting in the accumulation of transcription factors that promote MAGE gene transcription. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic Acid may enhance the transcription of MAGE genes through its interaction with retinoic acid receptors, which can bind to MAGE gene enhancer regions and stimulate gene expression. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $89.00 $250.00 | 32 | |
Temozolomide might induce the transcription of MAGE genes as a cellular response to its alkylating action on DNA, which can initiate a cascade of gene expression changes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin could prompt an increase in MAGE gene transcription as a part of the cellular response to DNA cross-linking damage, potentially leading to enhanced expression of stress response genes. |